{"created":"2023-05-15T14:45:44.259103+00:00","id":62487,"links":{},"metadata":{"_buckets":{"deposit":"4c7ffbd4-1cd0-42a3-97a3-828ac59c5a32"},"_deposit":{"created_by":1,"id":"62487","owners":[1],"pid":{"revision_id":0,"type":"depid","value":"62487"},"status":"published"},"_oai":{"id":"oai:repo.qst.go.jp:00062487","sets":["10:29"]},"author_link":["617361","617363","617369","617362","617368","617360","617370","617359","617364","617366","617365","617367"],"item_10005_date_7":{"attribute_name":"発表年月日","attribute_value_mlt":[{"subitem_date_issued_datetime":"2008-03-22","subitem_date_issued_type":"Issued"}]},"item_10005_description_5":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"Purpose: To estimate the toxicity and efficacy of carbon ion radiotherapy for skull base and paracervical tumors.\nMaterials and Methods: Between April 1997 and August 2007, a total of 46 patients with skull base or paracervical tumors have been treated with carbon ion radiotherapy for the phase I/II or phase II clinical trials.  The 46 patients consisting of 20 males and 26 females, their age range was from 16 to 78, with a median age of 50 years.  Histologically, 46 patients had 29 chordoma, 6 malignant meningioma, 7 chondrosarcoma, 3 olfactory neuroblastoma and one giant cell sarcoma.\nResults: Median follow-up time in 46 patients was 50 months (range, 4-122 months).  At the time of analysis, there was no evidence of any serious acute or late reactions.  The five-year local control rates according to prescribed tumor dose were 75% at 48 GyE (n=4), 67% at 52.8 GyE (n=6), 78% at 57.6 GyE (n=9) and 93% at 60.8 GE (n=27), respectively.  The five-year overall survival rates were 50% at 48 GyE, 100% at 52.8 GyE, 100% at 57.6 GyE and 76% at 60.8 GyE, respectively.  In 29 chordoma patients, they were divided into two groups; a low-dose group (n=10) irradiated with doses ranging from 48 to 57.8 GyE and a high-dose group (n=19) irradiated with a 60.8 GyE. The five-year local control rates were 60% for the low-dose group and 91% for the high-dose group.  The five-year overall survival rates were 89% for the low-dose group and 94% for the high-dose group. \nConclusions: Carbon ion radiotherapy will deliver a high local control rates with low toxicity to the surrounding normal tissues.","subitem_description_type":"Abstract"}]},"item_10005_description_6":{"attribute_name":"会議概要（会議名, 開催地, 会期, 主催者等）","attribute_value_mlt":[{"subitem_description":"NIRS-MD Anderson　Ｓｙｍｐｏｓｉｕｍ　ｏｎ　Ｃｌｉｎｉｃａｌ　ｌｓｓｕｅｓ　ｆｏｒ　Ｐａｒｔｉｃｌｅ　Ｔｈｅｒａｐｙ","subitem_description_type":"Other"}]},"item_access_right":{"attribute_name":"アクセス権","attribute_value_mlt":[{"subitem_access_right":"metadata only access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_14cb"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"Hasegawa, Azusa"}],"nameIdentifiers":[{"nameIdentifier":"617359","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Mizoe, Junetsu"}],"nameIdentifiers":[{"nameIdentifier":"617360","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Takagi, Ryo"}],"nameIdentifiers":[{"nameIdentifier":"617361","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Bessho, Hiroki"}],"nameIdentifiers":[{"nameIdentifier":"617362","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Onda, Takeshi"}],"nameIdentifiers":[{"nameIdentifier":"617363","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Tsujii, Hirohiko"}],"nameIdentifiers":[{"nameIdentifier":"617364","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"長谷川 安都佐","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"617365","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"溝江 純悦","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"617366","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"高木 亮","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"617367","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"別所 央城","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"617368","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"恩田 健志","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"617369","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"辻井 博彦","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"617370","nameIdentifierScheme":"WEKO"}]}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"conference object","resourceuri":"http://purl.org/coar/resource_type/c_c94f"}]},"item_title":"Carbon Ion Radiotherapy for Skull Base and Paracervical Tumors","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Carbon Ion Radiotherapy for Skull Base and Paracervical Tumors"}]},"item_type_id":"10005","owner":"1","path":["29"],"pubdate":{"attribute_name":"公開日","attribute_value":"2008-03-26"},"publish_date":"2008-03-26","publish_status":"0","recid":"62487","relation_version_is_last":true,"title":["Carbon Ion Radiotherapy for Skull Base and Paracervical Tumors"],"weko_creator_id":"1","weko_shared_id":-1},"updated":"2023-05-15T21:30:13.771433+00:00"}